Fig. 2From: The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomicsPOR rs10954732 polymorphisms related to decreased HCC susceptibility and increased OS of HCC patients as well as enzyme activity for CYP2E1 in healthy subjects and HCC patients. a Univariate logistic regression analysis of the association between rs10954732 polymorphisms and the risk of HCC. b Kaplan–Meier curve for overall survival (OS) of HCC patients between the GG genotype and GA + AA genotypes in HCC patients. Biochemical data (c) and CYP2E1 activity (d) in subjects between GG genotype and A allele carriers in healthy subjects and HCC patients. A allele carriers, GA + AA genotypes. Normal, healthy subjects. HCC, hepatocellular carcinoma. AST transaminase, ALT alanine aminotransferase, Vmax maximum reaction velocity, CLint intrinsic clearance. Data are expressed as mean ± SEM, P value was calculated by Mann–Whitney U testBack to article page